The biotech industry offers a compelling investment opportunity due to its potential for disruptive innovations and high ...

The board of directors of (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on December 10, 2024, to ...

Please read this leaflet carefully before you start using TRELEGY ELLIPTA. This leaflet answers some common questions about TRELEGY ELLIPTA. It does not contain all the available information.

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of flare-ups.

Ranked by Square feet of industrial space owned in Atlanta Ranked by Square feet developed, 2023-present Ranked by Retail sq. ft., local Showcase your company news with guaranteed exposure both in ...

Ranked by S.F. in metro-area tenant representation deals in 2023 Acentra Health combines public sector knowledge, clinical expertise, and technological ingenuity to modernize the healthcare ...

At a town hall meeting Monday night, Danville Police Chief Christopher Yates, asserted that Black drivers were “only two times more likely” to be pulled over for traffic stops than white drivers, ...